Therapeutic Tools for Vulvovaginal Candidiasis: Current and Emerging Antifungal Agents. [PDF]
Quindós G +6 more
europepmc +1 more source
Safety and efficacy of echinocandin antifungal agents in <i>Candida albicans</i> endophthalmitis. [PDF]
Zhang Y, Tang Y, Zhou Y, Wu H.
europepmc +1 more source
Characteristics of Candida isolates from patients with diabetes mellitus.
The present research has investigated the molecular characterization of oral yeasts in healthy individuals from different dental clinical settings in the United Kingdom, and patients from the UK and Italy who were affected by diabetes mellitus (DM) to ...
Manfredi, M.
core
<i>Candidozyma auris</i> susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents. [PDF]
Klamer KS +4 more
europepmc +1 more source
Pharmacovigilance insights: safety profiles of antifungal agents for invasive aspergillosis. [PDF]
Jia W, Wang T, Wang J.
europepmc +1 more source
Susceptibility of Candida auris isolates to antifungal agents: perspectives from whole-genome sequencing and phenotypic testing. [PDF]
Xie Z, Li Y, Yang F, Liu W, Cai R, Lu Y.
europepmc +1 more source
Clove oil and selenium nanoparticles as eco-friendly antifungal agents for photographic preservation. [PDF]
El-Sayed H, Osman ME, Ali N, Mohamed ET.
europepmc +1 more source
Unraveling the Mechanism of Perillyl Alcohol and Its Derivatives as Potent Antifungal Agents against Gray Mold. [PDF]
Shen S +10 more
europepmc +1 more source
Multicenter surveillance of antifungal susceptibility of clinical <i>Aspergillus</i> isolates to conventional and novel antifungal agents in Taiwan, 2021-2023. [PDF]
Hsieh M +4 more
europepmc +1 more source
Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology-Driven Delivery Strategies. [PDF]
E Silva DM +8 more
europepmc +1 more source

